Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

443 ARTÍCULOS , VIENDO DEL 361 AL 375

Chronic Spasticity Care

Baricich A, Battaglia M.

Phys Med Rehabil Clin N Am. 2026 May;37(2):201-212. doi: 10.1016/j.pmr.2026.01.008. Epub 2026 Feb 24.

SYNCRIP-Related Neurodevelopmental Disorder

Balasubramanian M, Bain JM, Gillentine MA.

2026 May 19. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

KIF1A-Related Neurodevelopmental Disorder

Chung W, Boyle L.

2026 Apr 2. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Modeling spasticity: a systematic review

González G, Marsden J, Besinis A, Borja P, Gunn H.

Prog Biomed Eng (Bristol). 2026 Feb 16;8(2). doi: 10.1088/2516-1091/ae3aed.

Fucosidosis

Stepien KM, Jones S, Wang R.

2026 Apr 2. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Adult-Onset PLA2G6-Associated Parkinsonism With Claval Hypertrophy: A Rare Radiological-Genetic Association

Mishra B, Mishra O, Nayak MK, Pradhan N, Sarangi PK.

Cureus. 2026 Jan 26;18(1):e102346. doi: 10.7759/cureus.102346. eCollection 2026 Jan.

Botulinum Toxin A Product Comparison for Upper Limb Spasticity, Lower Limb Spasticity, and Cervical Dystonia: Drugs

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2026 Jan. Report No.: RC1587.

A New Case of a Neurodevelopmental Disorder and Myoclonic Dystonia Associated with the C.1404del Variant of the ATP5F1A Gene

Krastev G, Danis M.

Int Med Case Rep J. 2026 Feb 19;19:573179. doi: 10.2147/IMCRJ.S573179. eCollection 2026.

A proposed preintervention framework for neurosurgery in children with medically refractory hypertonia: a scoping review

Abdelmageed S, Parikh R, Shahin MN, Krater T, Blackburn JS, Gilbert L, Raskin JS.

J Neurosurg Pediatr. 2026 Feb 6;37(5):464-475. doi: 10.3171/2025.9.PEDS25351.

Artificial Intelligence in Botulinum Toxin Injections: A Mini-Review of Current Applications, Challenges, and Translational Perspectives

Xu Q, Jia C, Xia X, Xu N, Liu J.

Cureus. 2026 May 15;18(5):e108898. doi: 10.7759/cureus.108898. eCollection 2026 May.

Comparative Analytics and Pharmacodynamics of the Complex Protein-Free Botulinum Toxin Type A Formulations DaxibotulinumtoxinA, IncobotulinumtoxinA and RelabotulinumtoxinA

Honndorf S, Kühbach K, Eisele KH, Shokurova A, Buch P, Jatzke C, Taylor HV, Fink K.

Toxins (Basel). 2026 Mar 14;18(3):142. doi: 10.3390/toxins18030142.

Neurosurgery to restore function in cerebral palsy: current practice and emerging therapies

Sankar A, Jobe A, McDonald B, Abel TJ, Sinha A, Piazza MG.

Front Rehabil Sci. 2026 Apr 15;7:1789774. doi: 10.3389/fresc.2026.1789774. eCollection 2026.

Achieving balance in upper limb spasticity management

Lam W, Leclercq C, Luria S, Rhee P.

J Hand Surg Eur Vol. 2026 Jun;51(6):737-746. doi: 10.1177/17531934261434453. Epub 2026 Mar 28.

CHMP2B-Related Frontotemporal Dementia-Amyotrophic Lateral Sclerosis

Roos P, Holm IE, Nielsen JE, Ejlerskov P, Toft A, Isaacs AM.

2007 Aug 23 [updated 2026 Mar 25]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Transdermal clonidine patch use in the management of childhood hypertonia: a cross-sectional UK-wide service evaluation

Lumsden DE, Spaull R, Abernethy S, El Gamal M, Forrest K, Lemaire LA, Lin JP, Marques S, Orr V, Carr L, De Alwis Y, Devlin A, Harrop E, Kurian M, Lundy CT, Mordekar S, Pysden K, Smallbone T, Lodh R.

Arch Dis Child. 2026 Feb 19;111(3):253-259. doi: 10.1136/archdischild-2025-329648.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias